Home > Insider Trading > Filing (0001628280-25-013284)

Filing Details

Accession Number:: 0001628280-25-013284
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-03-17 18:43:00
Reporting Period:: 2025-03-13

Filing Date:: 2025-03-17
Accepted Time:: 2025-03-17 18:43:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1311370	Lazard Inc.	LAZ	Investment Advice (6282)	980437848

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1837678	Richard Peter Orszag	C/O Lazard, Inc. 30 Rockefeller Plaza New York NY 10112	Ceo & Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-03-13	258,154	$0.00	376,809	No	4	M	Direct
Common Stock	Disposition	2025-03-13	77,446	$45.09	299,363	No	4	D	Direct
Common Stock	Disposition	2025-03-14	27,208	$44.87	272,155	No	4	S	Direct
Common Stock	Disposition	2025-03-14	37,331	$45.51	234,824	No	4	S	Direct
Common Stock	Disposition	2025-03-17	38,187	$45.31	196,637	No	4	S	Direct
Common Stock	Disposition	2025-03-17	26,352	$45.91	170,285	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	D	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Performance-based Restricted Participation Units	Disposition	2025-03-13	258,154	$0.00	258,154	$0.00
Common Stock	Restricted Participation Units	Acquisiton	2025-03-14	168,206	$0.00	168,206	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct
306,546			No	4	A	Direct

Footnotes

Shares of Common Stock were acquired upon the exchange of the Performance-based Restricted Participation Units ("PRPUs") referenced in Footnote (10).
Amount excludes 63,666 restricted stock units directly or indirectly beneficially owned by the Reporting Person.
Represents shares of Common Stock sold to the Company to cover estimated taxes arising from the exchange of PRPUs referenced in Footnote (10).
Represents the average of the high and low price of Common Stock on the New York Stock Exchange on the date of the exchange of the PRPUs referenced in Footnote (10).
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024. Sales of shares pursuant to the plan are intended to cover estimated taxes and other personal expenditures.
The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on March 14, 2025 in trades with average execution prices ranging from $44.31 to $45.31 inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report.
The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on March 14, 2025 in trades with average execution prices ranging from $45.32 to $45.87 inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report.
The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on March 17, 2025 in trades with average execution prices ranging from $44.80 to $45.80, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report.
The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on March 17, 2025 in trades with average execution prices ranging from $45.81 to $46.11, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report.
Represents a prior grant of PRPUs awarded with respect to compensation for 2021 of which performance and other conditions have been satisfied. The grant at target was reflected in the Company's proxy statement for the relevant year.
Each PRPU (the performance and other conditions of which have been satisfied) represents an interest in Lazard Group LLC that may be exchanged for one share of Common Stock.
Amount excludes a prior grant of 1,250,000 Stock Price Performance-based Restricted Participation Units, which was reflected in the Company's proxy statement for the relevant year.
These Restricted Participation Units ("RPUs") will vest on or around March 15, 2027.
Each RPU represents an interest in Lazard Group LLC that has satisfied its minimum value condition and that may be exchanged for one share of Common Stock.